These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 8256763)

  • 1. Echinomycin in recurrent and metastatic endometrial carcinoma. A phase II trial of the Gynecologic Oncology Group.
    Muss HB; Blessing JA; DuBeshter B
    Am J Clin Oncol; 1993 Dec; 16(6):492-3. PubMed ID: 8256763
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Echinomycin (NSC 526417) in recurrent and metastatic nonsquamous cell carcinoma of the cervix. A phase II trial of the Gynecologic Oncology Group.
    Muss HB; Blessing JA; Hanjani P; Malfetano JH; Kemp GM; Webster K
    Am J Clin Oncol; 1992 Aug; 15(4):363-4. PubMed ID: 1325110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Echinomycin (NSC 526417) in squamous-cell carcinoma of the cervix. A phase II trial of the Gynecologic Oncology Group.
    Muss HB; Blessing JA; Malfetano J
    Am J Clin Oncol; 1990 Jun; 13(3):191-3. PubMed ID: 2346124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Echinomycin (NSC 526417) in recurrent and metastatic squamous cell carcinoma of the cervix. A phase II trial of the Gynecologic Oncology Group (GOG).
    Muss HB; Blessing JA; Eddy GL; McGehee R
    Invest New Drugs; 1992 Apr; 10(1):25-6. PubMed ID: 1607251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Echinomycin (NSC 526417) in advanced ovarian cancer. A phase II trial of the Gynecologic Oncology Group.
    Muss HB; Blessing JA; Baker VV; Barnhill DR; Adelson MD
    Am J Clin Oncol; 1990 Aug; 13(4):299-301. PubMed ID: 2198794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase II trial of echinomycin in patients with advanced or recurrent colorectal cancer.
    Wadler S; Tenteromano L; Cazenave L; Sparano JA; Greenwald ES; Rozenblit A; Kaleya R; Wiernik PH
    Cancer Chemother Pharmacol; 1994; 34(3):266-9. PubMed ID: 8004762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase II study of carboplatin in patients with advanced or recurrent endometrial carcinoma. A trial of the EORTC Gynaecological Cancer Group.
    van Wijk FH; Lhommé C; Bolis G; Scotto di Palumbo V; Tumolo S; Nooij M; de Oliveira CF; Vermorken JB;
    Eur J Cancer; 2003 Jan; 39(1):78-85. PubMed ID: 12504662
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methotrexate in advanced endometrial carcinoma. A phase II trial of the Gynecologic Oncology Group.
    Muss HB; Blessing JA; Hatch KD; Soper JT; Webster KD; Kemp GM
    Am J Clin Oncol; 1990 Feb; 13(1):61-3. PubMed ID: 2407104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A phase II trial of vincristine in advanced or recurrent endometrial carcinoma. A Gynecologic Oncology Group Study.
    Broun GO; Blessing JA; Eddy GL; Adelson MD
    Am J Clin Oncol; 1993 Feb; 16(1):18-21. PubMed ID: 8424397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase II trial of echinomycin for the treatment of advanced renal cell carcinoma. A Southwest Oncology Group study.
    Marshall ME; Wolf MK; Crawford ED; Taylor S; Blumenstein B; Flanigan R; Meyers FJ; Hynes HE; Barlogie B; Eisenberger M
    Invest New Drugs; 1993; 11(2-3):207-9. PubMed ID: 8262733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized comparison of doxorubicin alone versus doxorubicin plus cyclophosphamide in the management of advanced or recurrent endometrial carcinoma: A Gynecologic Oncology Group study.
    Thigpen JT; Blessing JA; DiSaia PJ; Yordan E; Carson LF; Evers C
    J Clin Oncol; 1994 Jul; 12(7):1408-14. PubMed ID: 8021731
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase II trial of cisplatin as first-line chemotherapy in patients with advanced or recurrent endometrial carcinoma: a Gynecologic Oncology Group Study.
    Thigpen JT; Blessing JA; Homesley H; Creasman WT; Sutton G
    Gynecol Oncol; 1989 Apr; 33(1):68-70. PubMed ID: 2703169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase II trial of docetaxel in advanced or metastatic endometrial cancer: a Japanese Cooperative Study.
    Katsumata N; Noda K; Nozawa S; Kitagawa R; Nishimura R; Yamaguchi S; Aoki D; Susumu N; Kuramoto H; Jobo T; Ueki K; Ueki M; Kohno I; Fujiwara K; Sohda Y; Eguchi F
    Br J Cancer; 2005 Oct; 93(9):999-1004. PubMed ID: 16234823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase II trial of amonafide in patients with advanced metastatic or recurrent endometrial adenocarcinoma. A Southwest Oncology Group study.
    Malviya VK; Liu PY; O'Toole R; Alberts DS; Surwit E; Rosenoff S; Ward JH; Yu A; O'Sullivan J; Craig JB
    Am J Clin Oncol; 1994 Feb; 17(1):37-40. PubMed ID: 8311005
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A phase II trial of anastrozole in advanced recurrent or persistent endometrial carcinoma: a Gynecologic Oncology Group study.
    Rose PG; Brunetto VL; VanLe L; Bell J; Walker JL; Lee RB
    Gynecol Oncol; 2000 Aug; 78(2):212-6. PubMed ID: 10926805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of irofulven (MGI-114) in the treatment of recurrent or persistent endometrial carcinoma: A phase II study of the Gynecologic Oncology Group.
    Schilder RJ; Blessing JA; Pearl ML; Rose PG
    Invest New Drugs; 2004 Aug; 22(3):343-9. PubMed ID: 15122083
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A phase II trial of prolonged oral etoposide (VP-16) as second-line therapy for advanced and recurrent endometrial carcinoma: a Gynecologic Oncology Group study.
    Rose PG; Blessing JA; Lewandowski GS; Creasman WT; Webster KD
    Gynecol Oncol; 1996 Oct; 63(1):101-4. PubMed ID: 8898177
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A phase II Gynecologic Oncology Group trial of ifosfamide and mesna in advanced or recurrent adenocarcinoma of the endometrium.
    Sutton GP; Blessing JA; DeMars LR; Moore D; Burke TW; Grendys EC
    Gynecol Oncol; 1996 Oct; 63(1):25-7. PubMed ID: 8898163
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A phase II trial of topotecan in patients with advanced, persistent, or recurrent endometrial carcinoma: a gynecologic oncology group study.
    Miller DS; Blessing JA; Lentz SS; Waggoner SE
    Gynecol Oncol; 2002 Dec; 87(3):247-51. PubMed ID: 12468321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase I study of echinomycin.
    Pazdur R; Haas CD; Baker LH; Leichman CG; Decker D
    Cancer Treat Rep; 1987 Dec; 71(12):1217-9. PubMed ID: 3690532
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.